US FDA approves Regeneron's rare bone disorder drug - Reuters
US FDA approves Regeneron's rare bone disorder drug Reuters
The health section covers stories about medical progress, recovery, and wellbeing. We look for genuine advances: new therapies clearing regulatory hurdles, diseases being eradicated in specific regions, communities improving public health outcomes through evidence-based programs. Celebrity wellness trends and supplement marketing do not make the cut.
The morning letter delivers the day's best positive headlines before the rest of the internet gets loud. Free, no tracking, one click to leave.
Get the morning letter →
Hundreds of thousands of people with type 2 diabetes could get access to a new weekly insulin jab to replace daily injec…
A new jab extended the length of time patients were cancer free, but it is unclear for how long.
Moderna, Merck vaccine cuts recurrence and spread of melanoma, raising new treatment hope Reuters
Ultragenyx's gene therapy wins first FDA approval for rare metabolic disorder Reuters
Most news feeds won't give you another one. Our morning letter will: one email at sunrise with the day's best good news.
Start tomorrow morning →